Showing results (81-90 of 263) with videos related to
Sort By:
Pageof 27
Bone Marrow Transplantation|September 1, 1999
Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumoursG Fischmeister, A Zoubek, D Jugovic, et al.The New England Journal of Medicine|June 6, 1996
Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastomaI M Ambros, A Zellner, B Roald, et al.British Journal of Clinical Pharmacology|September 28, 2018
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal functionJ K Duong, G J Veal, C E Nath, et al.The EMBO Journal|March 28, 1998
Regulation of Drosophila Adh promoter switching by an initiator-targeted repression mechanismB Ren, T ManiatisJournal of Molecular Biology|April 5, 1989
X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligandsA Messerschmidt, A Rossi, R Ladenstein, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 10, 2018
Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net projectA Juan Ribelles, P Berlanga, G Schreier, et al.Proteins|May 21, 1998
Thermal unfolding of small proteins with SH3 domain folding patternS Knapp, P T Mattson, P Christova, et al.European Journal of Cancer (Oxford, England : 1990)|June 30, 2012
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trialG J Veal, L Nguyen, A Paci, et al.British Journal of Cancer|April 29, 2010
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task ForceK K Matthay, B Shulkin, R Ladenstein, et al.Bone Marrow Transplantation|July 24, 2008
28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 proceduresR Ladenstein, U Pötschger, O Hartman, et al.Pageof 27